{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.117.1.7.1.211",
  "meta" : {
    "versionId" : "34",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "TJC EH Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
      "valueString" : "VTE-01,VTE-02"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-01-24"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-02-20"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.117.1.7.1.211"
    }
  ],
  "version" : "20210220",
  "name" : "InjectableFactorXaInhibitorForVTEProphylaxis",
  "title" : "Injectable Factor Xa Inhibitor for VTE Prophylaxis",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-02-20T01:02:00-05:00",
  "publisher" : "TJC EH Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for medications of injectable factor Xa inhibitors used for venous thromboembolism (VTE) prophylaxis.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication that is an injectable factor Xa inhibitor.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "861356",
            "display" : "0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
          },
          {
            "code" : "861360",
            "display" : "0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe"
          },
          {
            "code" : "861363",
            "display" : "0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
          },
          {
            "code" : "861365",
            "display" : "0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:67402c17-8c2f-456d-8b15-db57d04e2f04",
    "timestamp" : "2024-11-09T00:38:28-05:00",
    "total" : 4,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "861356",
        "display" : "0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "861360",
        "display" : "0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "861363",
        "display" : "0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "861365",
        "display" : "0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"
      }
    ]
  }
}
